India’s Covid-19 tally tops 22 million with 403,738 new cases, 4,092 fresh fatalities
Skip to main content
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Splash
  • Features
  • Videos
  • Long Read
  • Games
  • Epaper
  • More
    • COVID-19
    • Bangladesh
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Subscribe
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
The Business Standard
MONDAY, MAY 23, 2022
MONDAY, MAY 23, 2022
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Splash
  • Features
  • Videos
  • Long Read
  • Games
  • Epaper
  • More
    • COVID-19
    • Bangladesh
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Subscribe
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
India’s Covid-19 tally tops 22 million with 403,738 new cases, 4,092 fresh fatalities

Coronavirus chronicle

Hindustan Times
09 May, 2021, 10:10 am
Last modified: 09 May, 2021, 12:23 pm

Related News

  • India considering spending additional $26 billion to fight inflation
  • India cuts excise duty on petrol, diesel; prices to drop by ₹9.5, ₹7 per litre
  • Bangladesh immigrants found guilty in Bengaluru gang rape case
  • Hindu women press for access to Indian mosque, in latest dispute
  • What justifies China’s zero-Covid policy?

India’s Covid-19 tally tops 22 million with 403,738 new cases, 4,092 fresh fatalities

With the latest addition, the total Covid-19 caseload has now soared to 22,296,414

Hindustan Times
09 May, 2021, 10:10 am
Last modified: 09 May, 2021, 12:23 pm
Health workers wearing personal protective equipment (PPE kit) attends to Covid-19 coronavirus positive patients inside a banquet hall temporarily converted into a covid care centre in New Delhi. Photo: AFP via Hindustan Times
Health workers wearing personal protective equipment (PPE kit) attends to Covid-19 coronavirus positive patients inside a banquet hall temporarily converted into a covid care centre in New Delhi. Photo: AFP via Hindustan Times

The coronavirus (Covid-19) pandemic continued to worsen in India as the trajectory maintained an upward trend. On Sunday, the nation added 403,738 to its tally as the national capital Delhi and other metro cities continue to report fresh infections, according to the Union ministry of health family welfare's daily bulletin. It is the fourth consecutive day when the number of daily infections is hovering above the 400,000 mark after recording a slight dip in daily cases.

The daily fatalities remained above 4,000 as 4,092 people died due to the viral infection, pushing the death toll to 242,362. With the latest addition, the total Covid-19 caseload has now soared to 22,296,414.

The number of active cases jumped to 3,736,648 and 18,317,404 people have recovered with 386,444 were discharged in a span of 24 hours, figures updated at 8am on the health ministry's dashboard showed.

Hospitals around the country have been overwhelmed by the fresh wave of infections with oxygen supplies running short in medical facilities due to the sudden surge in demand. People are running from pillar to post to secure even basic medicines.

On Saturday, Tamil Nadu joined a growing list of states with restrictions and announced a complete lockdown to curb the spread and ease pressure on the health system. The other states that are functioning under similar restrictions include Delhi, Maharashtra, Karnataka, Kerala, Rajasthan, Bihar among others.

On the vaccination front as well, the country is struggling to produce and distribute enough doses to stem the wave of Covid-19 as a long list of states are complaining of shortages, leading to the delay in immunisation drive. India is the world's biggest vaccine maker and it is currently using Covishield, developed by Oxford University and AstraZeneca and being manufactured by the Serum Institute of India, and Bharat Biotech's Covaxin for the inoculation drive.

On Saturday, the Drugs Controller General of India (DCGI) gave emergency approval to an anti-Covid oral drug called 2-deoxy-D-glucose, developed by the Defence Research and Development Organisation (DRDO) in joint cooperation with Hyderabad-based Dr Reddy's Laboratories Ltd.

According to the third phase of the clinical trial results, the drug helps in the faster recovery of hospitalised patients. It also reduced dependence on supplemental oxygen.

The country has administered over 167 million vaccine doses but its rate of inoculation has fallen in recent days and only around 2% of its 1.4 billion people have received the two doses needed to be fully immunised.

Top News / World+Biz

India / Covid -19

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • BPC hunts for dollar to import fuel oil
    BPC hunts for dollar to import fuel oil
  • Representational Image. Photo: Mumit M/TBS
    Govt to list products to suspend imports amid dollar crisis
  • Infographic: TBS
    With 2 months left, 45% ADP fund still unspent 

MOST VIEWED

  • A person in personal protective equipment (PPE) walks a dog at a resident community, as the second stage of a two-stage lockdown has been launched to curb the spread of the coronavirus disease (Covid-19) in Shanghai, China April 3, 2022. REUTERS/Aly Song
    Shanghai reopens some public transport, still on high Covid alert
  • Workers in protective suit spray disinfectant at a community, during the lockdown to curb the spread of the coronavirus disease (COVID-19) in Shanghai, China, April 5, 2022. REUTERS/Aly Song
    Dynamic zero-Covid approach: China's choice to safeguard lives, underpin growth
  • People wearing protective face masks walk on a street, following new cases of the coronavirus disease (Covid-19), in Shanghai, China August 25, 2021. REUTERS/Aly Song
    Shanghai district to require all shops to shut, residents to stay home
  • Photo: Courtesy
    Covax calls for urgent action to close vaccine equity gap
  • Photo: BSS/AFP
    Covax calls for urgent action to close vaccine equity gap
  • Photo: Collected
    Thousands of Covid-negative Beijing residents sent to quarantine

Related News

  • India considering spending additional $26 billion to fight inflation
  • India cuts excise duty on petrol, diesel; prices to drop by ₹9.5, ₹7 per litre
  • Bangladesh immigrants found guilty in Bengaluru gang rape case
  • Hindu women press for access to Indian mosque, in latest dispute
  • What justifies China’s zero-Covid policy?

Features

Why everybody wants to be like TikTok

Why everybody wants to be like TikTok

15h | Panorama
Illustration: TBS

How the ban on porn sites spawned a local cybersex industry

18h | Panorama
3 best affordable sunscreens for all

3 best affordable sunscreens for all

18h | Mode
Warah uses three types of khadi material: a sheer and light one, a medium count and a thicker one.

Warah: Embroidered with culture and womanhood

20h | Mode

More Videos from TBS

Investors, public to suffer from electricity price hike

Investors, public to suffer from electricity price hike

7h | Videos
Health benefits of summer fruits

Health benefits of summer fruits

9h | Videos
The way Bangladesh saves almost extinct fish

The way Bangladesh saves almost extinct fish

9h | Videos
Padma’s Char now largest grazing-ground

Padma’s Char now largest grazing-ground

9h | Videos

Most Read

1
Tk100 for bike, Tk2,400 for bus to cross Padma Bridge
Bangladesh

Tk100 for bike, Tk2,400 for bus to cross Padma Bridge

2
A packet of US five-dollar bills is inspected at the Bureau of Engraving and Printing in Washington March 26, 2015. REUTERS/Gary Cameron
Banking

Dollar hits Tk100 mark in open market

3
PK Halder: How a scamster rose from humble beginnings to a Tk11,000cr empire
Crime

PK Halder: How a scamster rose from humble beginnings to a Tk11,000cr empire

4
Bangladesh at risk of losing ownership of Banglar Samriddhi
Bangladesh

Bangladesh at risk of losing ownership of Banglar Samriddhi

5
BSEC launches probe against Abul Khayer Hero and allies
Stocks

BSEC launches probe against Abul Khayer Hero and allies

6
The story of Bangladesh becoming a major bicycle exporter
Industry

The story of Bangladesh becoming a major bicycle exporter

The Business Standard
Top
  • Home
  • Entertainment
  • Sports
  • About Us
  • Bangladesh
  • International
  • Privacy Policy
  • Comment Policy
  • Contact Us
  • Economy
  • Sitemap
  • RSS

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net

Copyright © 2022 THE BUSINESS STANDARD All rights reserved. Technical Partner: RSI Lab